Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sydney Lou Bonnick

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Bone|April 27, 2007
HSA: beyond BMD with DXASydney Lou Bonnick
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|November 5, 2011
Going on a drug holiday?Sydney Lou Bonnick
Current Opinion in Rheumatology|July 16, 2002
Current controversies in bone densitometrySydney Lou Bonnick
Current Opinion in Endocrinology, Diabetes, and Obesity|November 6, 2007
Noninvasive assessments of bone strengthSydney Lou Bonnick
Women'S Health (London, England)|December 17, 2008
Monitoring changes in bone densitySydney Lou Bonnick
The American Journal of Medicine|March 28, 2006
Monitoring osteoporosis therapy: bone mineral density, bone turnover markers, or both?Sydney Lou Bonnick, Lee Shulman
Gender Medicine|December 26, 2008
Descriptive analysis of concomitant prescription medication patterns from 1999 to 2004 among US women receiving daily or weekly oral bisphosphonate therapyDeborah T Gold, Sydney Lou Bonnick, Mayur M Amonkar, et al.
Journal of Women'S Health (2002)|July 1, 2009
Patient satisfaction in postmenopausal women treated with a weekly bisphosphonate transitioned to once-monthly ibandronateSydney Lou Bonnick, Stuart Silverman, S Bobo Tanner, et al.
Current Medical Research and Opinion|February 15, 2005
Response to therapy with once-weekly alendronate 70 mg compared to once-weekly risedronate 35 mg in the treatment of postmenopausal osteoporosisAnthony I Sebba, Sydney Lou Bonnick, Risa Kagan, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Bone|April 27, 2007
HSA: beyond BMD with DXASydney Lou Bonnick
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|November 5, 2011
Going on a drug holiday?Sydney Lou Bonnick
Current Opinion in Rheumatology|July 16, 2002
Current controversies in bone densitometrySydney Lou Bonnick
Current Opinion in Endocrinology, Diabetes, and Obesity|November 6, 2007
Noninvasive assessments of bone strengthSydney Lou Bonnick
Women'S Health (London, England)|December 17, 2008
Monitoring changes in bone densitySydney Lou Bonnick
The American Journal of Medicine|March 28, 2006
Monitoring osteoporosis therapy: bone mineral density, bone turnover markers, or both?Sydney Lou Bonnick, Lee Shulman
Gender Medicine|December 26, 2008
Descriptive analysis of concomitant prescription medication patterns from 1999 to 2004 among US women receiving daily or weekly oral bisphosphonate therapyDeborah T Gold, Sydney Lou Bonnick, Mayur M Amonkar, et al.
Journal of Women'S Health (2002)|July 1, 2009
Patient satisfaction in postmenopausal women treated with a weekly bisphosphonate transitioned to once-monthly ibandronateSydney Lou Bonnick, Stuart Silverman, S Bobo Tanner, et al.
Current Medical Research and Opinion|February 15, 2005
Response to therapy with once-weekly alendronate 70 mg compared to once-weekly risedronate 35 mg in the treatment of postmenopausal osteoporosisAnthony I Sebba, Sydney Lou Bonnick, Risa Kagan, et al.
Pageof 1